Loading organizations...
Loading organizations...
Biotechnology company focused on drug discovery and development.
Arthrosi Therapeutics has raised $243.0M across 3 funding rounds.
Arthrosi Therapeutics has raised $243.0M in total across 3 funding rounds.
Arthrosi Therapeutics has raised $243.0M in total across 3 funding rounds.
Arthrosi Therapeutics's investors include Prime Eight Capital, Cr, HM Venture Partners, ReliantTech, Guangrun Health Industry, Reichstein Biotech.
Arthrosi Therapeutics has raised $243.0M across 3 funding rounds. Most recently, it raised $153.0M Series E in October 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Oct 8, 2025 | $153.0M Series E | Prime Eight Capital | Cr, HM Venture Partners, ReliantTech |
| Jul 12, 2023 | $75.0M Series D | Guangrun Health Industry | Reichstein Biotech |
| Oct 23, 2020 | $15.0M Series C |